Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Frequency and Genetic Profile of Compound Heterozygous Friedreich's Ataxia Patients-the Brazilian Experience.

Peluzzo TM, Bonadia LC, Donatti A, Molck MC, Jardim LB, Marques W Jr, Lopes-Cendes IT, França MC Jr.

Cerebellum. 2019 Jun 26. doi: 10.1007/s12311-019-01055-z. [Epub ahead of print]

PMID:
31243663
2.

Copy number alterations associated with clinical features in an underrepresented population with breast cancer.

Rodrigues-Peres RM, de S Carvalho B, Anurag M, Lei JT, Conz L, Gonçalves R, Cardoso Filho C, Ramalho S, de Paiva GR, Derchain SFM, Lopes-Cendes I, Ellis MJ, Sarian LO.

Mol Genet Genomic Med. 2019 Jul;7(7):e00750. doi: 10.1002/mgg3.750. Epub 2019 May 16.

3.

Whole-exome sequencing indicates FLG2 variant associated with leg ulcers in Brazilian sickle cell anemia patients.

de Carvalho-Siqueira GQ, Ananina G, de Souza BB, Borges MG, Ito MT, da Silva-Costa SM, de Farias Domingos I, Falcão DA, Lopes-Cendes I, Bezerra MAC, da Silva Araújo A, Lucena-Araújo AR, de Souza Gonçalves M, Saad STO, Costa FF, de Melo MB.

Exp Biol Med (Maywood). 2019 May 12:1535370219849592. doi: 10.1177/1535370219849592. [Epub ahead of print]

PMID:
31079484
4.

Multimodal Analysis of SCN1A Missense Variants Improves Interpretation of Clinically Relevant Variants in Dravet Syndrome.

Gonsales MC, Montenegro MA, Preto P, Guerreiro MM, Coan AC, Quast MP, Carvalho BS, Lopes-Cendes I.

Front Neurol. 2019 Mar 28;10:289. doi: 10.3389/fneur.2019.00289. eCollection 2019.

5.

Association and interaction of genetic variants with occurrence of ischemic stroke among Brazilian patients.

Ferreira LE, Secolin R, Lopes-Cendes I, Cabral NL, França PHC.

Gene. 2019 May 5;695:84-91. doi: 10.1016/j.gene.2019.01.041. Epub 2019 Feb 8.

PMID:
30738964
6.

Normal cerebral cortical thickness in first-degree relatives of temporal lobe epilepsy patients.

Alhusaini S, Kowalczyk MA, Yasuda CL, Semmelroch MK, Katsurayama M, Zabin M, Zanão T, Nogueira MH, Alvim MKM, Ferraz VR, Tsai MH, Fitzsimons M, Lopes-Cendes I, Doherty CP, Cavalleri GL, Cendes F, Jackson GD, Delanty N.

Neurology. 2019 Jan 22;92(4):e351-e358. doi: 10.1212/WNL.0000000000006834. Epub 2018 Dec 26.

PMID:
30587513
7.

ATP Synthase Subunit Beta Immunostaining is Reduced in the Sclerotic Hippocampus of Epilepsy Patients.

Mota MVB, Zaidan BC, do Canto AM, Ghizoni E, Tedeschi H, de Souza Queiroz L, Alvim MKM, Cendes F, Lopes-Cendes I, Schenka AA, Vieira AS, Rogerio F.

Cell Mol Neurobiol. 2019 Jan;39(1):149-160. doi: 10.1007/s10571-018-0641-2. Epub 2018 Dec 11.

PMID:
30539418
8.

Developmental and neurodegenerative damage in Friedreich's ataxia.

Rezende TJR, Martinez ARM, Faber I, Girotto Takazaki KA, Martins MP, de Lima FD, Lopes-Cendes I, Cendes F, França MC Jr.

Eur J Neurol. 2019 Mar;26(3):483-489. doi: 10.1111/ene.13843. Epub 2018 Dec 5.

PMID:
30326180
9.

Structural signature in SCA1: clinical correlates, determinants and natural history.

Martins Junior CR, Martinez ARM, Vasconcelos IF, de Rezende TJR, Casseb RF, Pedroso JL, Barsottini OGP, Lopes-Cendes Í, França MC Jr.

J Neurol. 2018 Dec;265(12):2949-2959. doi: 10.1007/s00415-018-9087-1. Epub 2018 Oct 15.

PMID:
30324307
10.

SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response.

Faber I, Martinez ARM, Martins CR Jr, Maia ML, Souza JP, Lourenço CM, Marques W Jr, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Ramos CD, Lopes-Cendes Í, Friedman JH, Amorim BJ, França MC Jr.

Mov Disord. 2018 Oct;33(10):1650-1656. doi: 10.1002/mds.27491. Epub 2018 Oct 10.

PMID:
30306626
11.

Sudomotor dysfunction is frequent and correlates with disability in Friedreich ataxia.

Takazaki KAG, Rezende TJR, Martinez ARM, Gonzalez-Salazar C, Nucci A, Lopes-Cendes I, França MC Jr.

Clin Neurophysiol. 2018 Nov;129(11):2290-2295. doi: 10.1016/j.clinph.2018.08.017. Epub 2018 Aug 31.

PMID:
30227349
12.

Transcriptome of the Wistar audiogenic rat (WAR) strain following audiogenic seizures.

Damasceno S, Menezes NB, Rocha CS, Matos AHB, Vieira AS, Moraes MFD, Martins AS, Lopes-Cendes I, Godard ALB.

Epilepsy Res. 2018 Nov;147:22-31. doi: 10.1016/j.eplepsyres.2018.08.010. Epub 2018 Aug 29.

PMID:
30193173
13.

The Machado-Joseph disease-associated expanded form of ataxin-3: Overexpression, purification, and preliminary biophysical and structural characterization.

Contessotto MGG, Rosselli-Murai LK, Garcia MCC, Oliveira CLP, Torriani IL, Lopes-Cendes I, Murai MJ.

Protein Expr Purif. 2018 Dec;152:40-45. doi: 10.1016/j.pep.2018.07.005. Epub 2018 Jul 20.

PMID:
30036587
14.

Structural signature of SCA3: From presymptomatic to late disease stages.

Rezende TJR, de Paiva JLR, Martinez ARM, Lopes-Cendes I, Pedroso JL, Barsottini OGP, Cendes F, França MC Jr.

Ann Neurol. 2018 Sep;84(3):401-408. doi: 10.1002/ana.25297. Epub 2018 Sep 4.

PMID:
30014526
15.

SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.

Faber I, Martinez ARM, de Rezende TJR, Martins CR Jr, Martins MP, Lourenço CM, Marques W Jr, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Lopes-Cendes Í, França MC Jr.

Neuroimage Clin. 2018 Jun 9;19:848-857. doi: 10.1016/j.nicl.2018.05.031. eCollection 2018.

16.

Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.

Tavares de Andrade HM, Cintra VP, de Albuquerque M, Piccinin CC, Bonadia LC, Duarte Couteiro RE, Sabino de Oliveira D, Claudino R, Magno Gonçalves MV, Dourado MET Jr, de Souza LC, Teixeira AL, de Godoy Rousseff Prado L, Tumas V, Bulle Oliveira AS, Nucci A, Lopes-Cendes I, Marques W Jr, França MC Jr.

Neurobiol Aging. 2018 Sep;69:292.e15-292.e18. doi: 10.1016/j.neurobiolaging.2018.04.020. Epub 2018 May 8.

PMID:
29934271
17.

Role of non-coding RNAs in non-aging-related neurological disorders.

Vieira AS, Dogini DB, Lopes-Cendes I.

Braz J Med Biol Res. 2018 Jun 11;51(8):e7566. doi: 10.1590/1414-431X20187566. Review.

18.

Hippocampal microRNA-mRNA regulatory network is affected by physical exercise.

Fernandes J, Vieira AS, Kramer-Soares JC, Da Silva EA, Lee KS, Lopes-Cendes I, Arida RM.

Biochim Biophys Acta Gen Subj. 2018 Aug;1862(8):1711-1720. doi: 10.1016/j.bbagen.2018.05.004. Epub 2018 May 8.

PMID:
29746958
19.

Dysregulation of NEUROG2 plays a key role in focal cortical dysplasia.

Avansini SH, Torres FR, Vieira AS, Dogini DB, Rogerio F, Coan AC, Morita ME, Guerreiro MM, Yasuda CL, Secolin R, Carvalho BS, Borges MG, Almeida VS, Araújo PAOR, Queiroz L, Cendes F, Lopes-Cendes I.

Ann Neurol. 2018 Mar;83(3):623-635. doi: 10.1002/ana.25187. Epub 2018 Mar 10.

20.

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.

McCormack M, Gui H, Ingason A, Speed D, Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, Becker F, Rau S, Avbersek A, Heggeli K, Leu C, Depondt C, Sills GJ, Marson AG, Auce P, Brodie MJ, Francis B, Johnson MR, Koeleman BPC, Striano P, Coppola A, Zara F, Kunz WS, Sander JW, Lerche H, Klein KM, Weckhuysen S, Krenn M, Gudmundsson LJ, Stefánsson K, Krause R, Shear N, Ross CJD, Delanty N; EPIGEN Consortium;, Pirmohamed M, Carleton BC; Canadian Pharmacogenomics Network for Drug Safety;, Cendes F, Lopes-Cendes I, Liao WP, O'Brien TJ, Sisodiya SM; EpiPGX Consortium;, Cherny S, Kwan P, Baum L; International League Against Epilepsy Consortium on Complex Epilepsies;, Cavalleri GL.

Neurology. 2018 Jan 23;90(4):e332-e341. doi: 10.1212/WNL.0000000000004853. Epub 2017 Dec 29. Erratum in: Neurology. 2018 Oct 16;91(16):765.

21.

Joinville stroke biobank: study protocol and first year's results.

Ferreira LE, França PHC, Nagel V, Venancio V, Safanelli J, Reis FID, Furtado L, Martins RK, Weiss G, Oda E, Lopes-Cendes I, Pontes-Neto O, Cabral NL.

Arq Neuropsiquiatr. 2017 Dec;75(12):881-889. doi: 10.1590/0004-282X20170157.

22.

Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.

Facchini G, Ignarro RS, Rodrigues-Silva E, Vieira AS, Lopes-Cendes I, Castilho RF, Rogerio F.

J Neurooncol. 2018 Feb;136(3):435-443. doi: 10.1007/s11060-017-2672-9. Epub 2017 Nov 20.

PMID:
29159775
23.

Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives.

Gambardella A, Labate A, Mumoli L, Lopes-Cendes I, Cendes F.

Curr Pharm Des. 2017;23(37):5760-5765. doi: 10.2174/1381612823666170911111536. Review.

PMID:
28891449
24.

Exploratory structural assessment in craniocervical dystonia: Global and differential analyses.

Vilany L, de Rezende TJR, Piovesana LG, Campos LS, de Azevedo PC, Torres FR, França MC Jr, Amato-Filho AC, Lopes-Cendes I, Cendes F, D'Abreu A.

PLoS One. 2017 Aug 22;12(8):e0182735. doi: 10.1371/journal.pone.0182735. eCollection 2017.

25.

Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?

Rabelo AG, Teixeira CV, Magalhães TN, Carletti-Cassani AFM, Amato Filho AC, Joaquim HP, Talib LL, Forlenza O, Ribeiro PA, Secolin R, Lopes-Cendes I, Cendes F, Balthazar ML.

Neuroradiol J. 2017 Oct;30(5):477-485. doi: 10.1177/1971400917720465. Epub 2017 Jul 17.

26.

Silencing of P2X7R by RNA interference in the hippocampus can attenuate morphological and behavioral impact of pilocarpine-induced epilepsy.

Amorim RP, Araújo MGL, Valero J, Lopes-Cendes I, Pascoal VDB, Malva JO, da Silva Fernandes MJ.

Purinergic Signal. 2017 Dec;13(4):467-478. doi: 10.1007/s11302-017-9573-4. Epub 2017 Jul 13.

27.

Acute liver failure is associated with altered cerebral expression profiles of long non-coding RNAs.

Silva VR, Secolin R, Vemuganti R, Lopes-Cendes I, Hazell AS.

Neurosci Lett. 2017 Aug 24;656:58-64. doi: 10.1016/j.neulet.2017.06.038. Epub 2017 Jun 23.

PMID:
28648459
28.

Structural signature of classical versus late-onset friedreich's ataxia by Multimodality brain MRI.

Rezende TJR, Martinez ARM, Faber I, Girotto K, Pedroso JL, Barsottini OG, Lopes-Cendes I, Cendes F, Faria AV, França MC.

Hum Brain Mapp. 2017 Aug;38(8):4157-4168. doi: 10.1002/hbm.23655. Epub 2017 May 23.

PMID:
28543952
29.

Cerebellar Gray Matter Alterations in Huntington Disease: A Voxel-Based Morphometry Study.

de Azevedo PC, Guimarães RP, Piccinin CC, Piovesana LG, Campos LS, Zuiani JR, Tamashiro EM, Pinheiro G, Amato-Filho AC, Cendes F, Lopes-Cendes I, D'Abreu A.

Cerebellum. 2017 Dec;16(5-6):923-928. doi: 10.1007/s12311-017-0865-6.

PMID:
28528357
30.

Spinal Cord Damage in Spinocerebellar Ataxia Type 1.

Martins CR Jr, Martinez ARM, de Rezende TJR, Branco LMT, Pedroso JL, Barsottini OGP, Lopes-Cendes I, França MC Jr.

Cerebellum. 2017 Aug;16(4):792-796. doi: 10.1007/s12311-017-0854-9.

PMID:
28386793
31.

MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy.

Avansini SH, de Sousa Lima BP, Secolin R, Santos ML, Coan AC, Vieira AS, Torres FR, Carvalho BS, Alvim MK, Morita ME, Yasuda CL, Pimentel-Silva LR, Dogini DB, Rogerio F, Cendes F, Lopes-Cendes I.

PLoS One. 2017 Apr 6;12(4):e0173060. doi: 10.1371/journal.pone.0173060. eCollection 2017.

32.

17p13.3 Microdeletion: Insights on Genotype-Phenotype Correlation.

Barros Fontes MI, Dos Santos AP, Rossi Torres F, Lopes-Cendes I, Cendes F, Appenzeller S, Kawasaki de Araujo T, Lopes Monlleó I, Gil-da-Silva-Lopes VL.

Mol Syndromol. 2017 Jan;8(1):36-41. doi: 10.1159/000452753. Epub 2016 Nov 25.

33.

A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.

Silva-Alves MS, Secolin R, Carvalho BS, Yasuda CL, Bilevicius E, Alvim MK, Santos RO, Maurer-Morelli CV, Cendes F, Lopes-Cendes I.

PLoS One. 2017 Jan 4;12(1):e0169214. doi: 10.1371/journal.pone.0169214. eCollection 2017.

34.

A new phenotype associated with homozygous GRN mutations: complicated spastic paraplegia.

Faber I, Prota JR, Martinez AR, Lopes-Cendes I, França MC Júnior.

Eur J Neurol. 2017 Jan;24(1):e3-e4. doi: 10.1111/ene.13194. No abstract available.

PMID:
28000352
35.

Cyclooxygenase-1 as a Potential Therapeutic Target for Seizure Suppression: Evidences from Zebrafish Pentylenetetrazole-Seizure Model.

Barbalho PG, Carvalho BS, Lopes-Cendes I, Maurer-Morelli CV.

Front Neurol. 2016 Nov 15;7:200. eCollection 2016.

36.

Lithium carbonate and coenzyme Q10 reduce cell death in a cell model of Machado-Joseph disease.

Lopes-Ramos CM, Pereira TC, Dogini DB, Gilioli R, Lopes-Cendes I.

Braz J Med Biol Res. 2016 Nov 21;49(12):e5805. doi: 10.1590/1414-431X20165805.

37.

Cdc2-like kinase 2 in the hypothalamus is necessary to maintain energy homeostasis.

Quaresma PG, Weissmann L, Zanotto TM, Santos AC, de Matos AH, Furigo IC, Simabuco FM, Donato J Jr, Bittencourt JC, Lopes-Cendes I, Prada PO.

Int J Obes (Lond). 2017 Feb;41(2):268-278. doi: 10.1038/ijo.2016.174. Epub 2016 Oct 13.

PMID:
27733761
38.

Inflammatory demyelinating neuropathy heralding accelerated chediak-higashi syndrome.

Faber IV, Prota JRM, Martinez ARM, Nucci A, Lopes-Cendes I, Júnior MCF.

Muscle Nerve. 2017 May;55(5):756-760. doi: 10.1002/mus.25414. Epub 2017 Feb 3.

PMID:
27669550
39.

MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.

de Andrade HM, de Albuquerque M, Avansini SH, de S Rocha C, Dogini DB, Nucci A, Carvalho B, Lopes-Cendes I, França MC Jr.

J Neurol Sci. 2016 Sep 15;368:19-24. doi: 10.1016/j.jns.2016.06.046. Epub 2016 Jun 22.

PMID:
27538595
40.

Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells.

Ignarro RS, Facchini G, Vieira AS, De Melo DR, Lopes-Cendes I, Castilho RF, Rogerio F.

Mol Cell Biochem. 2016 Jul;418(1-2):167-78. doi: 10.1007/s11010-016-2742-x. Epub 2016 Jun 23.

PMID:
27334753
41.

Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Martinez AR, Nunes MB, Faber I, D'Abreu A, Lopes-Cendes Í, França MC Jr.

Cerebellum. 2017 Feb;16(1):118-121. doi: 10.1007/s12311-016-0775-z.

PMID:
27021342
42.
43.

New THAP1 mutation and role of putative modifier in TOR1A.

Piovesana LG, Torres FR, Azevedo PC, Amaral TP, Lopes-Cendes I, D'Abreu A.

Acta Neurol Scand. 2017 Feb;135(2):183-188. doi: 10.1111/ane.12579. Epub 2016 Mar 4.

PMID:
26940431
44.

RNA sequencing reveals region-specific molecular mechanisms associated with epileptogenesis in a model of classical hippocampal sclerosis.

Vieira AS, de Matos AH, do Canto AM, Rocha CS, Carvalho BS, Pascoal VD, Norwood B, Bauer S, Rosenow F, Gilioli R, Cendes F, Lopes-Cendes I.

Sci Rep. 2016 Mar 3;6:22416. doi: 10.1038/srep22416.

45.

Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations.

Servelhere KR, Faber I, Saute JA, Moscovich M, D'Abreu A, Jardim LB, Teive HA, Lopes-Cendes I, Franca MC Jr.

Eur J Neurol. 2016 Feb;23(2):408-11. doi: 10.1111/ene.12839.

PMID:
26806216
46.

Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes.

Martinez AR, Moro A, Abrahao A, Faber I, Borges CR, Rezende TJ, Martins CR Jr, Moscovich M, Munhoz RP, Segal SL, Arruda WO, Saraiva-Pereira ML, Karuta S, Pedroso JL, D'Abreu A, Jardim LB, Lopes-Cendes Í, Barsottini OG, Teive HA, França MC Jr.

Cerebellum. 2017 Feb;16(1):253-256. doi: 10.1007/s12311-015-0755-8.

PMID:
26754264
47.

Longitudinal magnetic resonance imaging study shows progressive pyramidal and callosal damage in Friedreich's ataxia.

Rezende TJ, Silva CB, Yassuda CL, Campos BM, D'Abreu A, Cendes F, Lopes-Cendes I, França MC Jr.

Mov Disord. 2016 Jan;31(1):70-8. doi: 10.1002/mds.26436. Epub 2015 Dec 21.

PMID:
26688047
48.

Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.

Nunes MB, Martinez AR, Rezende TJ, Friedman JH, Lopes-Cendes I, D'Abreu A, França MC Jr.

Parkinsonism Relat Disord. 2015 Dec;21(12):1441-7. doi: 10.1016/j.parkreldis.2015.10.016. Epub 2015 Oct 30.

PMID:
26552869
49.

Recent developments in the genetics of childhood epileptic encephalopathies: impact in clinical practice.

Gonsales MC, Montenegro MA, Soler CV, Coan AC, Guerreiro MM, Lopes-Cendes I.

Arq Neuropsiquiatr. 2015 Nov;73(11):946-58. doi: 10.1590/0004-282X20150122. Epub 2015 Oct 6. Review.

50.

Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway.

Quaresma PG, Reencober N, Zanotto TM, Santos AC, Weissmann L, de Matos AH, Lopes-Cendes I, Folli F, Saad MJ, Prada PO.

Int J Obes (Lond). 2016 Jan;40(1):138-46. doi: 10.1038/ijo.2015.134. Epub 2015 Jul 31.

PMID:
26228462

Supplemental Content

Loading ...
Support Center